TY - JOUR
T1 - Impact of Hemodialysis on Clinical Outcomes in Patients Undergoing Lower Extremity Bypass Surgery for Peripheral Artery Disease—10-year Follow-Up Study
AU - Kumada, Yoshitaka
AU - Kawai, Norikazu
AU - Ishida, Narihiro
AU - Mori, Akihiro
AU - Ishii, Hideki
AU - Ohshima, Satoru
AU - Ito, Ryuta
AU - Umemoto, Norio
AU - Takahashi, Hiroshi
AU - Murohara, Toyoaki
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/9
Y1 - 2022/9
N2 - We investigated the clinical impact of hemodialysis on long-term outcomes of bypass surgery in patients with peripheral artery disease. We evaluated 660 consecutive patients who underwent successful bypass surgery (392 hemodialysis and 268 non-hemodialysis). The endpoint was amputation-free survival (AFS). To minimize differences in clinical characteristics between the 2 groups, propensity score matching was performed. The AFS rates for 10-year follow-up were 39.3% and 67.7% in hemodialysis and non-hemodialysis patients [hazard ratio (HR) 2.21, 95% confidence interval (CI) 1.65–3.01, P <.0001]. Cumulative incidence of amputation was higher in the hemodialysis group than in the non-hemodialysis group [(19.4 vs 8.4%, HR 2.15, 95% CI 1.29–3.74, P =.0027). In a matched cohort (n = 210 each), AFS was still lower in the hemodialysis patients (53.1 vs 66.3%, HR 1.94, 95% CI 1.36–2.82, P =.0003). However, there was no significant difference in amputation rate between the groups (10.5 vs 10.6%, HR.97, 95% CI 0.49–1.87, P =.93). In a sub-analysis of patients with critical limb ischemia, similar results were obtained. The 10-year AFS was consistently lower in the hemodialysis group than in the non-hemodialysis group. However, the amputation rate was comparable between the groups when matched for the differences in clinical characteristics.
AB - We investigated the clinical impact of hemodialysis on long-term outcomes of bypass surgery in patients with peripheral artery disease. We evaluated 660 consecutive patients who underwent successful bypass surgery (392 hemodialysis and 268 non-hemodialysis). The endpoint was amputation-free survival (AFS). To minimize differences in clinical characteristics between the 2 groups, propensity score matching was performed. The AFS rates for 10-year follow-up were 39.3% and 67.7% in hemodialysis and non-hemodialysis patients [hazard ratio (HR) 2.21, 95% confidence interval (CI) 1.65–3.01, P <.0001]. Cumulative incidence of amputation was higher in the hemodialysis group than in the non-hemodialysis group [(19.4 vs 8.4%, HR 2.15, 95% CI 1.29–3.74, P =.0027). In a matched cohort (n = 210 each), AFS was still lower in the hemodialysis patients (53.1 vs 66.3%, HR 1.94, 95% CI 1.36–2.82, P =.0003). However, there was no significant difference in amputation rate between the groups (10.5 vs 10.6%, HR.97, 95% CI 0.49–1.87, P =.93). In a sub-analysis of patients with critical limb ischemia, similar results were obtained. The 10-year AFS was consistently lower in the hemodialysis group than in the non-hemodialysis group. However, the amputation rate was comparable between the groups when matched for the differences in clinical characteristics.
KW - C-reactive protein
KW - amputation
KW - hemodialysis
KW - lower extremity bypass surgery
KW - peripheral artery disease
UR - http://www.scopus.com/inward/record.url?scp=85124531773&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124531773&partnerID=8YFLogxK
U2 - 10.1177/00033197211070882
DO - 10.1177/00033197211070882
M3 - Article
C2 - 35108110
AN - SCOPUS:85124531773
SN - 0003-3197
VL - 73
SP - 744
EP - 752
JO - Angiology
JF - Angiology
IS - 8
ER -